Manufacturer or GPO Program year 2025 Source: CMS Open Payments

Amgen Inc.

CA, United States

CMS manufacturer 100000000203

Open in the dashboard

General payments

$235,085,390

2,746,859 payments

Research payments

$2,147,348,515

37,108 payments

Ownership & investment interest

$0

None reported

Through program year 2025, Amgen Inc. reported paying $235,085,390 in general payments and $2,147,348,515 in research payments to U.S. physicians, teaching hospitals and other recipients.

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

14 rows
Year Kind Amount Payments
2025 General $45,848,289 504,233
2025 Research $584,648,345 5,053
2024 General $44,921,708 474,864
2024 Research $298,125,891 4,940
2023 General $26,813,892 376,215
2023 Research $174,509,775 2,110
2022 General $25,840,932 403,270
2022 Research $141,022,008 2,495
2021 General $26,565,568 364,490
2021 Research $352,069,115 5,448
2020 General $21,868,029 231,485
2020 Research $306,677,770 9,319
2019 General $43,226,973 392,302
2019 Research $290,295,611 7,743

Breakdown

Top recipients General payments · program year 2025
  1. Dana-Farber Cancer Institute Teaching hospital · MA $4,099,651 6 payments
  2. Brian Druker Hematology & Oncology · Portland, OR $555,495 54 payments
  3. Massachusetts General Hospital Teaching hospital · MA $499,000 1 payment
  4. Hospital For Special Surgery Teaching hospital · NY $495,000 1 payment
  5. Brigham And Womens Hospital Teaching hospital · MA $272,137 3 payments
  6. Ronald Reagan Ucla Teaching hospital · CA $236,576 4 payments
  7. Adam Kilian Rheumatology · Saint Louis, MO $199,788 174 payments
  8. Cleveland Clinic Hospital Teaching hospital · OH $186,950 5 payments
  9. Don Kikkawa Ophthalmology · La Jolla, CA $180,116 64 payments
  10. Mary Klotman Internal Medicine · Durham, NC $155,758 33 payments
Top research recipients Research payments · program year 2025
  1. Fortrea Clinical Research Unit Inc. $48,206,734 29 payments
  2. Nci Clinical Repository $32,281,347 1 payment
  3. Ut Md Anderson Cancer Center Teaching hospital · TX $24,132,903 34 payments
  4. University Of Washington Med Ctr Teaching hospital · WA $15,587,216 9 payments
  5. New York University Grossman School Of Medicine And New York University Langone Hospitals $11,596,540 15 payments
  6. Brigham And Womens Hospital Teaching hospital · MA $10,203,908 20 payments
  7. D And H National Research Centers INC $9,332,048 4 payments
  8. City Of Hope National Medical Ctr Teaching hospital · CA $8,475,008 36 payments
  9. Clinpro Research Solutions LLC $8,351,811 1 payment
  10. Interspond Llc $8,310,855 29 payments
Products the payments named General payments · program year 2025
  1. Uplizna Inflammation/Rare Disease $7,677,410 19% · 7,419 recipients
  2. Repatha Cardiovascular $6,910,533 17% · 55,847 recipients
  3. Otezla Inflammation $6,843,263 17% · 48,655 recipients
  4. Evenity Bone Health $5,252,079 13% · 29,168 recipients
  5. Krystexxa Inflammation/Rare Disease $4,186,615 10% · 14,568 recipients

The top 5 of 35 products; each share is of this company’s general payments naming a product in 2025. A payment can name up to five products, so these amounts overlap.

The top 25 products, free in the app

Specialties paid General payments · program year 2025
  1. Rheumatology Internal Medicine $6,490,955 17% · 3,040 practitioners
  2. Dermatology $2,827,852 7% · 4,545 practitioners
  3. Neurology Psychiatry & Neurology $2,519,392 7% · 2,310 practitioners
  4. Endocrinology, Diabetes & Metabolism Internal Medicine $2,463,082 6% · 2,901 practitioners
  5. Internal Medicine $2,315,124 6% · 12,718 practitioners

The top 5 of 264 specialties; each share is of this company’s general payments to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2025
  1. Massachusetts $5,580,641 12% · 1,439 recipients
  2. California $5,334,201 12% · 11,096 recipients
  3. New York $3,756,572 8% · 8,171 recipients
  4. Texas $3,646,985 8% · 11,471 recipients
  5. Florida $3,325,211 7% · 11,782 recipients

The top 5 of 54 states; each share is of this company’s general payments in 2025 where a state was reported.

The top 25 states, free in the app

What the payments were for General payments · program years 2019–2025
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $119,116,469 60,534 payments
  2. Food and Beverage $58,647,749 2,606,444 payments
  3. Consulting Fee $25,607,503 9,556 payments
  4. Travel and Lodging $15,274,501 49,608 payments
  5. Royalty or License $8,542,450 124 payments
  6. Charitable Contribution $3,032,979 38 payments
  7. Education $1,921,943 19,423 payments
  8. Space rental or facility fees (teaching hospital only) $1,689,233 963 payments
  9. Grant $1,035,539 40 payments
  10. Honoraria $194,175 110 payments
2,746,859 general · 37,108 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers of drugs, devices and biologicals, and group purchasing organisations, are required to report the payments and transfers of value they make to physicians and teaching hospitals. This page shows what this company reported.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record